Delivery Order SPE2DE23D0008-SPE2D626F99F1
Award Date 1/7/26
Potential Completion Date 1/9/26
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,990 delivery order for Natrelle TE Smooth 133S-MX-11-T breast implants by the Defense Logistics Agency's Medical Supply Chain division on January 7, 2026. The contract is a fixed-price delivery order with economic price adjustment provisions, with a completion date of January 13, 2026. The order will be fulfilled from the company's facility in Irvine, California. This delivery order was issued without any small business set-aside...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $2,990.00 for Natrelle TE Smooth 133S-MV-14-T breast implants under a fixed-price contract with economic price adjustment. The award was issued on September 11, 2025, with an ultimate completion date of September 25, 2025, and carries no set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. The product will be delivered to Irvine, California,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $23,920 by the Defense Logistics Agency's Medical Supply Chain division on December 12, 2025, for Natrelle TE Smooth 133S-FV-12-T breast implants. The contract is structured as a fixed-price agreement with economic price adjustment and carries an ultimate completion date of December 16, 2025. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider of these...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on July 10, 2025, for Natrelle TE Smooth 133S breast implants. This delivery order, which carries an ultimate completion date of July 28, 2025, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicle contracts established with DLA Troop Support Medical on December 8, 2022. The award was made without...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $3,404.00 for Natrelle TE Smooth 133S-MX-14-T breast implants on July 24, 2025. This delivery order, issued without set-aside designation, represents a child contract under Allergan's larger Indefinite Delivery Vehicle (IDV) agreements with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is funded through the Medical Supply Chain division of DLA and involves fixed-price...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,495 fixed-price delivery order for NATRELLE TE Smooth 133S-MX-15-T breast implants on August 14, 2025, with an ultimate completion date of August 18, 2025. This contract was funded by the Medical Supply Chain division of the Defense Logistics Agency and will be performed in Irvine, California. The award carries no set-aside designation, reflecting Allergan's status as a sole-source provider of specialized breast implant...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a fixed-price delivery order valued at $2,990.00 for Natrelle TE Smooth 133S-MV-13-T breast implants from the Defense Logistics Agency Troop Support Medical division on January 7, 2026, with an ultimate completion date of February 6, 2026. This delivery order was awarded without a set-aside designation and represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle agreements. The place of performance is...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $2,990 fixed-price delivery order with economic price adjustment for Natrelle TE Smooth 133S-MV-12-T breast implants. The contract was awarded on January 7, 2026, with a completion date of January 13, 2026, and will be performed in Irvine, California. The award carries no small business set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices to the federal government. This...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on November 26, 2025, with completion scheduled for December 1, 2025. The contract covers the delivery of Natrelle Inspira SCM 485CC breast implants to support surgical procedures at military treatment facilities and related federal healthcare systems. This delivery order was issued without a set-aside designation, reflecting...